John Smith is considered one of the country’s premiere experts on non-invasive glucose monitoring technology. He previously served as Vice President and Chief Scientific Officer of Johnson & Johnson’s LifeScan, a world market leader in blood glucose monitoring systems. John now consults for companies pursuing noninvasive glucose methods, and for investors who fund them. He is the author of The Pursuit of Noninvasive Glucose: “Hunting the Deceitful Turkey,” which is available for download here. He’s…Read more »
I hereby interrupt my vacation to bring you some exciting diabetes technology news. Some of you may know that the American Association of Diabetes Educators (AADE) is holding its annual conference in Atlanta on Aug. 5-8. This event takes a close second to the ADA’s big annual shindig in June as the biggest event of the year for launching new diabetes products and programs.
Some cool stuff being officially unveiled next week:
* A new…Read more »
Being diagnosed with diabetes at any age is a shock, but being diagnosed at 18 years old when you’re studying to be prima ballerina in New York City has to be a HUGE shock. That’s what happened to Zippora Karz, who now teaches dance from her home in Los Angeles. This November, at age 44, she’ll be publishing The Sugarless Plum: A Ballerina’s Triumph over Diabetes, her memoirs of diagnosis and time in the New…Read more »
It’s difficult to describe the feeling of being physically in the same room with 30 people with whom you have a longstanding online intimacy, seeing their faces and hearing their voices in the flesh. With the likes of David Mendosa, Jeff Hitchcock, Manny Hernandez, Scott King, Kerri Sparling, Fran Carpentier, and a whole mess of other bloggers and heads of online D-communities gathered, it felt something like a meeting of the mafia bosses — in…Read more »
The New York Times reports today that the rise in the use of home glucose monitors, also in hospitals, is pushing the Food and Drug Administration toward a possible crack-down on accuracy standards. Some of you might say it’s about time, considering that current standards allow a margin for error of up to 20%, which can make a huge difference in the choices we make on food, exercise, and in particular insulin doses.